Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Lebersche kongenitale Amaurose 02

Lebersche kongenitale Amaurose 2 ist eine autosomal rezessive Erkrankung, die auf Mutationen des RPE65-Gens beruht.

Gliederung

Lebersche kongenitale Amaurose
Lebersche kongenitale Amaurose 01
Lebersche kongenitale Amaurose 02
RPE65
Lebersche kongenitale Amaurose 03
Lebersche kongenitale Amaurose 04
Lebersche kongenitale Amaurose 05
Lebersche kongenitale Amaurose 06
Lebersche kongenitale Amaurose 07
Lebersche kongenitale Amaurose 08
Lebersche kongenitale Amaurose 09
Lebersche kongenitale Amaurose 10
Lebersche kongenitale Amaurose 11
Lebersche kongenitale Amaurose 12
Lebersche kongenitale Amaurose 13
Lebersche kongenitale Amaurose 14
Lebersche kongenitale Amaurose 15
Lebersche kongenitale Amaurose 16
Lebersche kongenitale Amaurose 17
Lebersche kongenitale Amaurose 18

Referenzen:

1.

Narfström K et al. (1989) The Briard dog: a new animal model of congenital stationary night blindness.

external link
2.

Wrigstad A et al. (1994) Slowly progressive changes of the retina and retinal pigment epithelium in Briard dogs with hereditary retinal dystrophy. A morphological study.

external link
3.

Marlhens F et al. (1997) Mutations in RPE65 cause Leber's congenital amaurosis.

external link
4.

Morimura H et al. (1998) Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or leber congenital amaurosis.

external link
5.

Aguirre GD et al. (1998) Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect.

external link
6.

Yzer S et al. (2003) A Tyr368His RPE65 founder mutation is associated with variable expression and progression of early onset retinal dystrophy in 10 families of a genetically isolated population.

external link
7.

Al-Khayer K et al. (2004) Thirty-year follow-up of a patient with leber congenital amaurosis and novel RPE65 mutations.

external link
8.

WAARDENBURG PJ et al. (1963) ON VARIOUS RECESSIVE BIOTYPES OF LEBER'S CONGENITAL AMAUROSIS.

external link
9.

Chung DC et al. (2009) Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions.

external link
10.

Maguire AM et al. (2008) Safety and efficacy of gene transfer for Leber's congenital amaurosis.

external link
11.

Bainbridge JW et al. (2008) Effect of gene therapy on visual function in Leber's congenital amaurosis.

external link
12.

Hauswirth WW et al. (2008) Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.

external link
13.

Cideciyan AV et al. (2008) Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.

external link
14.

Cideciyan AV et al. (2009) Vision 1 year after gene therapy for Leber's congenital amaurosis.

external link
15.

Maguire AM et al. (2009) Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

external link
16.

OMIM.ORG article

Omim 204100 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz